The development of a 195Aum generator provides a short half-life (30.5 s) radiotracer for first-pass nuclear angiocardiography with significantly lower radiation exposure than 99Tcm.
Answers are grounded in this paper and cite their sources.
May enable lower-radiation first-pass studies; hypothesis-generating and requires prospective validation before adoption.
The development of a mercury-195m/gold-195m radionuclide generator system is described, together with the results of preliminary experiments in animals and in man. The daughter radionuclide has a half-life of 30.5 s with a principal gamma emission at 262 keV, ideal for use with the multicrystal camera but suitable also in conjunction with the Anger design. The half-life of the parent radionuclide is 40 h. The eluant in current use is 2.5 mM sodium cyanide, the column being stored under 2% sodium nitrate solution when not in use to prevent radiation damage. Generators capable of delivering 550 MBq of 195Aum in a 0.4 ml bolus have been used for first-pass nuclear angiocardiography, the half-life being long enough to permit administration via peripheral intravenous injection. The radiation dose associated with this radionuclide is much lower than that from conventional 99Tcm-labelled radiopharmaceuticals, permitting multiple sequential studies, even on children.
No takes yet. Share an insight, caveat, or question.
Elliott et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: